Generics in Germany

Generics in Germany

Summary

Generics in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

  • A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.
  • The German generics market recorded revenues of $27.7 billion in 2023, representing a compound annual growth rate (CAGR) of 4.2% between 2018 and 2023.
  • Market consumption volume increased with a CAGR of 1.5% between 2018 and 2023, to reach a total of 89.0% of total pharma volume in 2023.
  • The German generics market is driven by the tax incentives for pharmaceutical research & development. For instance, in December 2023, the German Federal Government launched a National Pharmaceutical Strategy to promote a sustainable and internationally competitive pharmaceutical industry.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Germany
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Germany
  • Leading company profiles reveal details of key generics market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Germany generics market with five year forecasts
Reasons to Buy
  • What was the size of the Germany generics market by value in 2023?
  • What will be the size of the Germany generics market in 2028?
  • What factors are affecting the strength of competition in the Germany generics market?
  • How has the market performed over the last five years?
  • What are the main segments that make up Germany's generics market?


1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading player?
7.3. Has the government recently implemented any initiatives aimed at boosting the market?
8 Company Profiles
8.1. Teva Pharmaceutical Industries Ltd
8.2. Novartis AG
8.3. Bayer AG
8.4. Stada Arzneimittel AG
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Germany generics market value: $ million, 2018-23
Table 2: Germany generics market volume: % of total pharma volume, 2018-23
Table 3: Germany generics market geography segmentation: $ million, 2023
Table 4: Germany generics market value forecast: $ million, 2023-28
Table 5: Germany generics market volume forecast: % of total pharma volume, 2023-28
Table 6: Teva Pharmaceutical Industries Ltd: Key Facts
Table 7: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Ltd: Key Employees
Table 9: Novartis AG: Key Facts
Table 10: Novartis AG: Annual Financial Ratios
Table 11: Novartis AG: Key Employees
Table 12: Bayer AG: Key Facts
Table 13: Bayer AG: Annual Financial Ratios
Table 14: Bayer AG: Key Employees
Table 15: Bayer AG: Key Employees Continued
Table 16: Bayer AG: Key Employees Continued
Table 17: Stada Arzneimittel AG: Key Facts
Table 18: Stada Arzneimittel AG: Key Employees
Table 19: Germany Size of Population (million), 2019-23
Table 20: Germany Real GDP (Constant 2010 Prices, $ Billion) 2019-23
Table 21: Germany GDP (Current Prices, $ Billion), 2019-23
Table 22: Germany Inflation, 2019-23
Table 23: Germany Consumer Price Index (Absolute), 2019-23
Table 24: Germany Exchange Rate, 2018-23
List of Figures
Figure 1: Germany generics market value: $ million, 2018-23
Figure 2: Germany generics market volume: % of total pharma volume, 2018-23
Figure 3: Germany generics market geography segmentation: % share, by value, 2023
Figure 4: Germany generics market value forecast: $ million, 2023-28
Figure 5: Germany generics market volume forecast: % of total pharma volume, 2023-28
Figure 6: Forces driving competition in the generics market in Germany, 2023
Figure 7: Drivers of buyer power in the generics market in Germany, 2023
Figure 8: Drivers of supplier power in the generics market in Germany, 2023
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Germany, 2023
Figure 10: Factors influencing the threat of substitutes in the generics market in Germany, 2023
Figure 11: Drivers of degree of rivalry in the generics market in Germany, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings